Mr Arthur Lynn Cook, LMFT | |
200 Nw 4th St, Bryant, AR 72022-3424 | |
(501) 847-5660 | |
Not Available |
Full Name | Mr Arthur Lynn Cook |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 200 Nw 4th St, Bryant, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093293193 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | M0611010 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Arthur Lynn Cook, LMFT 121 Waterside Dr, Maumelle, AR 72113-5838 Ph: (501) 529-9138 | Mr Arthur Lynn Cook, LMFT 200 Nw 4th St, Bryant, AR 72022-3424 Ph: (501) 847-5660 |
News Archive
The comparable safety and efficacy of switching patients to a biosimilar anti-TNF-α monoclonal antibody from the reference medicinal product (RMP) has been further established in data presented at EULAR 2015, the annual meeting of the European League Against Rheumatism.
The U.S. Food and Drug Administration today announced a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma, a very rare type of cancer.
Stereotactic radiosurgery (SRS) for cancer patients who receive the treatment for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall survival (OS) or distant brain metastases (DBMs) rates, when compared to observation alone following surgical resection of brain metastases, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
Medtronic announced today that the United States Court of Appeals for the Federal Circuit affirmed that the Pivot system offered by Globus Medical infringes two patents owned by Medtronic.
According to data appearing today in JAMA, patients with a common heart rhythm disorder, called Atrial Fibrillation, who were treated with catheter ablation using the NAVISTAR® THERMOCOOL® Catheter, demonstrated significantly better outcomes at one year compared to those receiving drug therapy. In addition, the patients treated with catheter ablation reported markedly fewer symptoms and substantially improved quality of life.
› Verified 7 days ago